Global Guillain-Barre Syndrome Market Share

Statistics for the 2023 & 2024 Global Guillain-Barre Syndrome market share, created by Mordor Intelligence™ Industry Reports. Global Guillain-Barre Syndrome share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Global Guillain-Barre Syndrome Industry

The Guillain-Barre Syndrome market is moderately competitive and consists of several major players. Various strategies, such as the acquisition of the products by other companies, consolidate the market positions across the globe. Some of the companies currently dominating the market are Grifols S.A., CSL Limited, Octapharma AG, Kedrion Biopharma Inc., and Takeda Pharmaceutical Company Limited, among others.

Guillain-Barre Syndrome Market Leaders

  1. CSL Behring LLC

  2. Takeda Pharmaceutical Company Limited

  3. Grifols SA

  4. Kedrion Biopharma Inc.

  5. Octapharma AG

*Disclaimer: Major Players sorted in no particular order

Guillain-Barre Syndrome Market Concentration

Guillain-Barre Syndrome Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)